Navigation Links
Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research
Date:9/2/2014

NEW YORK, September 2, 2014 /PRNewswire/ --

Persistence Market Research (http://www.persistencemarketresearch.com/) "Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019" the global membrane technology market for pharmaceutical, biopharma and life sciences is estimated at USD 7,029.9 million in 2014 and is expected to grow at a CAGR of 9.1% from 2014 to 2019, to reach an estimated value of USD 10,886.0 million in 2019.

Browse the full Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019 report at http://www.persistencemarketresearch.com/market-research/membrane-technology-market.asp

The membrane technology market in pharmaceutical, biopharma and life sciences is growing due to increased research and development and production in pharmaceutical, biopharmaceutical and life sciences industries. Moreover, stringent regulations and usage of single-use disposable technique are also playing a major role in growth of the membrane technology market. Presence of various filtration techniques such as ultrafiltration, nanofiltration and microfiltration under membrane technology has increased its acceptance in pharmaceutical, biopharmaceutical and life science industries for separation and purification of components and biomolecules, over conventional techniques. 

However, the market faces some restraints such as effects of membrane fouling, high operational and investment cost and limitation of membrane materials. As a result, the market is expected to grow at a CAGR of about 9.1% during 2014-2019. 

North America is the largest market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. The U.S. is the world's largest market for pharmaceutical and biopharmaceutical products. According to the European Federation of Pharmaceutical Industries and Associations, North America accounted for about 41% of global pharmaceutical sales in 2012. 

Similarly, in Europe, membrane technology is a rapidly growing sector with many associations, organizations and societies actively involved in expansion and implementation of this technology in various industries including pharmaceutical, biopharmaceutical and life sciences. However, Asia is the fastest growing region in the membrane technology market due to continuous development in pharmaceutical and biopharmaceutical industries. 

Recent Published Market Reports by Persistence Market Research:  

The global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.

The global home infusion therapy market is estimated at USD 15.9 billion in 2014 and is expected to reach USD 26.7 billion by 2020, growing at a CAGR of 9.0% from 2014 to 2020. 

The global flavored and functional water market was valued at USD 17.2 billion in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 36.7 billion in 2019.

GE Healthcare Life Sciences and 3M are some of the leading players in the global membrane technology market in pharmaceutical, biopharma and life sciences. Other major players of the membrane technology market include Pall Corporation, Sartorius, Merck Millipore, Koch Membrane Systems Inc., Novasep, TriSep Corporation, Amazon Filters Ltd. and Advantec MFS.

The global market of membrane technology in pharmaceutical, biopharma and life sciences is segmented as follows:

Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences, By Technology 

  • Ultrafiltration
  • Microfiltration
  • Nanofiltration
  • Chromatography

Browse the full report With TOC at http://www.persistencemarketresearch.com/market-research/membrane-technology-market.asp

Membrane Technology Market in Pharamceutical, Biopharma and Life Sciences, by Geography 

  • North America
    • U.S.
  • Europe
    • Switzerland
    • Germany
    • Italy
    • U.K.
    • Ireland
    • France
  • Asia
    • China
    • India
    • Japan
    • Malaysia
    • Singapore
  • Rest of the World (RoW)

Latest Market Press Releases: http://www.persistencemarketresearch.com/media-releases.asp

About Us: 

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us:

Addie Thomas
305 Broadway
7th Floor
New York City, NY 10007, USA
Tel: No. +1-646-568-7751
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Market Survey Articles: http://www.persistencemarketresearch.com/articles.asp


'/>"/>
SOURCE Persistence Market Research
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Oncothyreon to Present at Rodman & Renshaw Global Investment Conference
2. 9.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com
3. Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com
4. Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research
5. Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
6. Global Biodegradable Packaging Materials Market 2014-2018
7. Global Chelating Agents Market 2014-2018
8. Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019
9. Global Enzyme for Pulp & Paper Industry Report 2014
10. Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014
11. AMRI CEO to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
(Date:2/15/2017)... ... February 15, 2017 , ... Executive ... Chief Commercial Officer with GenePeeks. Matt is a veteran life sciences and ... computational genomics company focused on identifying inherited disease risk in future generations. In ...
(Date:2/15/2017)... , Feb. 15, 2017  NASA provider SpaceX is ... to the  International Space Station  no earlier than 10:01 ... launch will begin at 8:30 a.m. on NASA Television ... Dragon spacecraft will lift off on the company,s ... Kennedy Space Center in ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/24/2017)... NEW YORK , Jan. 24, 2017 /PRNewswire/ ... market study of the laboratory use of nuclear ... of 363 experienced end-users and profiled current practices, ... three years, as well as growth and opportunities. ... NMR, Instrument suppliers, NMR instruments, needs and innovation ...
Breaking Biology News(10 mins):